Loading…
Yasons Chemex Care (YCCL)₹12.20+19.61%Dyes And Pigments
In the Mar 2026 quarter (consolidated), Yasons Chemex Care reported sales of ₹47.38 Cr, up 0.8% from Mar 2025, and net profit of −₹0.09 Cr. For the year to Mar 2026, sales were ₹96.47 Cr and net profit ₹0.95 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 24.71 | 37.44 | 31.61 | 29.32 | 47.01 | 49.10 | 47.38 |
| Expenses | 25.05 | 34.56 | 32.07 | 26.78 | 48.44 | 47.52 | 49.86 |
| Operating Profit | −0.30 | 2.99 | −0.38 | 2.58 | −1.33 | 1.74 | −2.34 |
| OPM % | −1.2% | 7.9% | −1.2% | 8.7% | −2.8% | 3.5% | −4.9% |
| Other Income | 1.53 | 1.08 | −0.12 | 0.62 | 2.19 | 0.14 | 3.65 |
| Interest | 0.22 | 0.48 | 0.83 | 0.67 | 0.74 | 0.60 | 0.65 |
| Depreciation | 0.04 | 0.20 | 0.20 | 0.18 | 0.18 | 0.03 | 0.32 |
| Profit before tax | 0.94 | 3.34 | −1.52 | 2.30 | −0.07 | 1.20 | 0.31 |
| Tax % | 22.1% | 15.5% | 2.0% | 18.6% | 225.0% | 16.5% | 125.0% |
| Net Profit | 0.75 | 2.83 | −1.58 | 1.89 | −0.26 | 1.03 | −0.09 |
| EPS (Rs) | 0.51 | 1.47 | −0.82 | 0.98 | −0.14 | 0.52 | −0.05 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 36.64 | 36.68 | 69.02 | 76.30 | 96.47 |
| Expenses | 36.29 | 36.27 | 66.63 | 75.21 | 97.36 |
| Operating Profit | 0.50 | 0.50 | 2.61 | 1.28 | −0.60 |
| OPM % | 1.3% | 1.3% | 3.7% | 1.7% | −0.6% |
| Other Income | 4.24 | 4.24 | 0.97 | 2.79 | 3.78 |
| Interest | 0.40 | 0.40 | 1.32 | 1.43 | 1.27 |
| Depreciation | 0.09 | 0.09 | 0.42 | 0.37 | 0.36 |
| Profit before tax | 4.20 | 4.20 | 1.79 | 2.22 | 1.52 |
| Tax % | 18.8% | 18.7% | 30.6% | 27.4% | 38.6% |
| Net Profit | 3.44 | 3.44 | 1.26 | 1.63 | 0.95 |
| EPS (Rs) | 5.80 | 2.41 | 0.66 | 0.85 | 0.50 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 14.19 | 19.32 | 19.32 | 19.33 |
| Reserves | 6.55 | 19.75 | 21.34 | 22.22 |
| Borrowings | 3.46 | 8.50 | 11.14 | 13.35 |
| Other Liabilities | 3.40 | 6.97 | 7.46 | 12.97 |
| Total Liabilities | 27.60 | 54.54 | 59.26 | 67.87 |
| Fixed Assets | 0.53 | 3.16 | 2.85 | 2.73 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 6.61 | 0.00 | 0.00 | 0.00 |
| Other Assets | 20.46 | 51.38 | 56.41 | 65.14 |
| Inventories | 8.07 | 14.97 | 19.48 | 20.96 |
| Trade receivables | 11.37 | 28.64 | 30.08 | 41.85 |
| Cash & equivalents | 0.07 | 1.45 | 1.27 | 1.30 |
| Total Assets | 27.60 | 54.54 | 59.26 | 67.87 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from operating activity | −0.28 | −16.24 | −2.46 | −0.75 |
| Cash from investing activity | 0.07 | 0.00 | −0.02 | −0.25 |
| Cash from financing activity | 0.23 | 17.57 | 1.21 | 0.92 |
| Net cash flow | 0.02 | 1.37 | −1.22 | −0.06 |
| Capex | 0.00 | 0.03 | 0.07 | 0.25 |
| Free cash flow | −0.26 | −16.22 | −2.50 | −0.97 |
| CFO / OP % | 59.0% | −599.0% | −136.0% | −10.0% |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor days | 112 | 150 | 143 | 157 |
| Inventory days | 84 | 85 | 97 | 82 |
| Days payable | 31 | 27 | 25 | 41 |
| Cash conversion cycle | 167 | 210 | 217 | 200 |
| Working capital days | 141 | 183 | 175 | 142 |
| ROCE % | — | 8.7% | 7.4% | 5.3% |
For the Mar 2026 quarter, Yasons Chemex Care reported sales of ₹47.38 Cr, up 0.8% year on year and net profit of −₹0.09 Cr. The operating margin was −4.9%.
Yasons Chemex Care's sales for the year to Mar 2026 were ₹96.47 Cr.
Net profit for the year to Mar 2026 was ₹0.95 Cr. Earnings per share over the same trailing period were ₹0.50.
Yasons Chemex Care reported borrowings of ₹13.35 Cr at Mar 2026, against cash and equivalents of ₹1.30 Cr.
Cash from operations was −₹0.75 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.97 Cr.